|
|
Article: Stellar Pharmaceuticals' Q3-2009 Financial Results Marked by Strong Growth and Continued Profitability.
- Article from:
- Marketwire Canada
- Article date:
- November 6, 2009
CopyrightCOPYRIGHT 2009 Canadian Corporate News. News Provided by Comtex. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
LONDON, ONTARIO, Nov 6, 2009 (Marketwire via COMTEX) -- Stellar Pharmaceuticals Inc. ("Stellar" or "the Company") (OTCBB:SLXCF), a Canadian pharmaceutical developer and marketer of high quality, cost-effective products for select health care markets, today announced its financial results for the third quarter ended September 30, 2009. In this press release, unless otherwise indicated, all dollar amounts are expressed in Canadian dollars and have been rounded to nearest hundred.
Q3-2009 Highlights
- Revenues grew 71.9% over the same three-month period in 2008
- Gross profit grew by 41.7% for the quarter
- Net income for the quarter grew ...